RA
AZN icon

Riversedge Advisors’s AstraZeneca AZN Stock Holding History

Riversedge Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Sell
2,280
-483
-17% -$90.8K 0.06% 142
2026
Q1 		$545K Buy
2,763
+40
+1% +$7.71K 0.09% 78
2025
Q4 		$501K Buy
2,723
+283
+12% +$49.6K 0.08% 78
2025
Q3 		$374K Buy
2,440
+411
+20% +$62.2K 0.06% 97
2025
Q2 		$284K Sell
2,029
-222
-10% -$31.1K 0.06% 89
2025
Q1 		$331K Buy
+2,251
New +$326K 0.07% 83

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Riversedge Advisors's AZN Position: Q2 2026 in Review

Riversedge Advisors reduced its AstraZeneca (AZN) stake by 17% in Q2 2026, selling an estimated $90.8K and leaving 2,280 shares worth $432K. The position accounts for 0.06% of the portfolio, ranked #142.

Riversedge Advisors first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. The position peaked at $545K in Q1 2026. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Riversedge Advisors held 2,280 shares of AstraZeneca worth $432K as of Q2 2026.
  • Riversedge Advisors sold 483 AstraZeneca shares in Q2 2026, an estimated $90.8K.
  • AstraZeneca made up 0.06% of Riversedge Advisors's portfolio in Q2 2026, its #142 holding.
  • Riversedge Advisors first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
  • Riversedge Advisors's AstraZeneca position peaked at $545K in Q1 2026.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Riversedge Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.